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Rapid detection of metallo--lactamase (MBL)-producing gram-negative bacilli is necessary to prevent their
dissemination. The method using a disk with imipenem plus 750 g of EDTA differentiated all MBL-producing
pseudomonads, and the sensitivity and specificity for acinetobacters were 95.7 and 91.0%, respectively. The
imipenem-EDTA disks were stable for 12 and 16 weeks at 4 and 20°C, respectively.
An increasing prevalence of carbapenem resistance medi-
ated by acquired metallo--lactamases (MBLs) is being re-
ported, particularly for Pseudomonas aeruginosa clinical iso-
lates in several countries (4, 6, 8, 9, 11–14, 17, 18). In Korea,
approximately 10 and 50% of imipenem resistance in P. aerugi-
nosa (8) and Acinetobacter spp. (19), respectively, are due to
MBL production. The resistance may spread rapidly to various
species of gram-negative bacilli, as the MBL genes reside in
mobile gene cassettes inserted in integrons (3). The rapid de-
tection of MBL-positive gram-negative bacilli is necessary to
aid infection control and to prevent their dissemination (5). A
PCR method was simple to use in detecting MBL-producing
isolates initially (16), but it became more difficult with the
increased number of types of MBLs.
MBL activity is inhibited by chelating agents. Double-disk
synergy tests using a ceftazidime disk and a 2-mercaptopropi-
onic acid disk (1), or an imipenem disk and an EDTA disk (7),
have been reported as a simple method to detect MBL-pro-
ducing clinical isolates. However, occasional adjustment of the
distance between the two disks is required to obtain optimal
results (1, 7), as is the case with the double-disk test for the
detection of extended-spectrum -lactamase-producing iso-
lates (2). For the phenotypic confirmation of extended-spec-
trum--lactamase-producing isolates, inhibition zones are
compared by using both ceftazidime and cefotaxime disks with
and without clavulanic acid (10). The aim of this study was to
determine the feasibility of using an imipenem disk with added
EDTA to confirm MBL-producing clinical isolates of Pseudo-
monas spp. and Acinetobacter spp.
The MBL-producing gram-negative bacilli used in this study
were 102 isolates of P. aeruginosa, 14 of Pseudomonas putida,
20 of Acinetobacter baumannii, and 3 of Acinetobacter genomo-
species 3. All of the isolates were VIM-2 MBL producers
except for one isolate of P. aeruginosa and five isolates of
acinetobacters, which were IMP-1 MBL producers. MBL
genes were detected by PCR, and MBL production was de-
tected by the imipenem-EDTA double-disk synergy test as
described previously (8). Imipenem-resistant or -intermediate
but non-carbapenemase-producing isolates were included for
comparison.
Test organisms were inoculated onto plates of Mueller-Hin-
ton agar (Becton Dickinson, Cockeysville, Md.) as recom-
mended by the National Committee for Clinical Laboratory
Standards (10). A 0.5 M EDTA solution was prepared by
dissolving 186.1 g of disodium EDTA  2H2O (Junsei Chemi-
cal, Tokyo, Japan) in 1,000 ml of distilled water and adjusting
it to pH 8.0 by using NaOH. The mixture was sterilized by
autoclaving (15). Two 10-g-imipenem disks (Becton Dickin-
son) were placed on the plate, and appropriate amounts of an
EDTA solution were added to one of them to obtain the
desired concentration. The inhibition zones of the imipenem
and imipenem-EDTA disks were compared after 16 to 18 h of
incubation in air at 35°C.
To test the stability of the EDTA-added imipenem disks, an
EDTA solution was added to 10-g-imipenem disks to obtain
a concentration of 1,000 g. The disks were dried immediately
in an incubator and stored at 4 or at 20°C in airtight vials
without desiccant. The inhibition zones produced for MBL-
positive and -negative isolates were compared after storage of
the disks.
A preliminary study showed that a disk with imipenem plus
150 g of EDTA could increase the mean inhibition zone
diameter by 12 mm for four MBL-positive P. aeruginosa iso-
lates, but the increase was only 6 mm for three MBL-positive
Acinetobacter isolates. A disk with imipenem plus 1,500 g
of EDTA increased the mean inhibition zones for three
MBL-negative isolates by 7 mm. Therefore, 750- and 1,000-g
EDTA concentrations were chosen for further study.
Figure 1 shows inhibition zones for MBL-positive and -neg-
ative imipenem-resistant pseudomonads and acinetobacters
produced by disks with imipenem alone and disks with imi-
penem plus 750 g of EDTA (data for the disk with imipenem
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plus 1,000 g of EDTA are not shown). For MBL-positive
isolates of Pseudomonas spp., disks with imipenem plus 750
and 1,000 g of EDTA increased inhibition zones by 8 to 15
mm (mean, 10.5 mm) and 9 to 16 mm (mean, 11.5 mm),
respectively, while the increases for MBL-negative isolates
were 1 to 5 mm (mean, 3.8 mm) and 2 to 6 mm (mean, 5.0
mm), respectively (data not shown). The inhibition zone diam-
eter for MBL-positive Acinetobacter spp. increased by 6 to 13
mm (mean, 9.4 mm) and 7 to 14 mm (mean, 10.4 mm), respec-
tively, while that for MBL-negative isolates increased by 1 to 7
mm (mean, 4.0 mm) and 3 to 9 mm (mean, 6.0 mm), respec-
tively. The disks with imipenem plus 750 g of EDTA and
those with imipenem plus 1,000 g of EDTA produced com-
parable results, and therefore, a disk containing 750 g of
EDTA was chosen.
With Pseudomonas spp., all of the MBL-positive isolates
were well separated from MBL-negative isolates by the crite-
rion of a 7-mm increase of inhibition zone with the disks to
which 750 g of EDTA was added (Fig. 1B). However, by the
same criterion, 1 of 23 (4.3%) MBL-positive and 1 of 11 (9.1%)
MBL-negative acinetobacters showed false-negative and false-
positive results, respectively (Fig. 1B). The size of inhibition
zones was helpful for resolving this problem with equivocal
isolates. The inhibition zones with imipenem-EDTA disks
were 14 mm for the MBL-negative isolates, while they were
17 mm for the MBL-positive isolates (Fig. 1A).
FIG. 1. Comparison of inhibition zone diameters produced by disks with imipenem and imipenem plus 750 g of EDTA. (A) Scattergram
comparing inhibition zone diameters. Boldface indicates imipenem-resistant or -intermediate, but MBL-negative isolates, and lightface indicates
MBL-positive isolates. (B) Increased inhibition zones with imipenem-EDTA disks. IMP, imipenem.
VOL. 40, 2002 NOTES 3799
A ceftazidime disk method was reported elsewhere to be
more sensitive than an imipenem disk method for the detec-
tion of MBL by the double-disk synergy test (1). However, the
use of a 2-mercaptopropionic acid-containing ceftazidime disk
was not considered in this study, because the chemical is vol-
atile and the MICs of imipenem for all of our MBL-producing
isolates were 8 g/ml.
An EDTA stock solution is stable, but addition of the solu-
tion at each performance of the test is time-consuming. To
determine the stability of imipenem disks containing 1,000 g
of EDTA, the dried disks were stored at 4 or at 20°C without
desiccant to simulate the most unfavorable laboratory condi-
tion. The inhibition zones with the imipenem-EDTA disks did
not decrease much for one each of MBL-positive or -negative,
imipenem-resistant P. aeruginosa and A. baumannii isolates for
12 and 16 weeks at 4 or at 20°C, respectively (Table 1). The
imipenem-susceptible P. aeruginosa ATCC 27853 showed only
slightly smaller inhibition zones with the imipenem-EDTA disk
than with imipenem disks for routine use. The inhibition zone
for the National Committee for Clinical Laboratory Standards
control strain was within the acceptable range (10) for at least
24 weeks.
In conclusion, the method using a disk with imipenem plus
750 g of EDTA is simple to perform and highly sensitive in
differentiating MBL-producing isolates. The specificity was ex-
cellent for pseudomonads and good for acinetobacters. The
imipenem-EDTA disks can be stored at 20°C without signif-
icant loss of activity for at least 16 weeks.
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